Dr. Vishal Anil Patel, MD, Director of Cutaneous Oncology and Dermatologic Surgery, is featured in an article emphasizing the role of coordinated care between dermatologists and oncologists in monitoring and managing adverse events related to immunotherapy in CSCC and BCC. For more information, please click here.
Monitoring Immunotherapy Toxicities in CSCC and BCC
Latest News
Frequent interruptions to sleep and daytime sleepiness may be indicative of sleep apnea and warrant a consultation with a sleep expert.
January is peak resolution season — whether it’s a plan to get organized at work or home, volunteer in the community, or read more — the new year is the perfect opportunity to make a fresh start. After weeks of parties and lavish meals over the holiday season, perhaps the most common resolution out…
In the latest installment of the GW Medicine Bicentennial Lecture Series, Julie E. Bauman led a panel of leading cancer researchers who explored the future of cancer treatment. The hour-long lecture, titled “Harnessing the Immune System Against Cancer—From Shots to Stem Cells,” delved into…